Skip to content
TrackPodcasts
newsMay 1, 202415:41pending

Concerns over MDH spices, SC on VVPATs, and AstraZeneca's admission

3 Things

About this episode

First, Indian Express’ Anonna Dutt joins us to talk about why Hong Kong and Singapore withdrew products from MDH and Everest and how FSSAI has responded to it. 

Next, Indian Express’ Damini Nath talks to us about the voting process and the verdict that was recently given by the Supreme Court of India regarding the EVMs and VVPATs. (5:15)

And finally, we talk about  AstraZeneca, the pharmaceutical company that created the Covid-19 vaccine - Covishield and its admission of the fact that their vaccine causes series health issues. (12:12)

Hosted by Niharika Nanda
Produced and written by Niharika Nanda and Shashank Bhargava
Edited and mixed by Suresh Pawar

Get every episode summarized

Each time 3 Things publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.

Email me new episodes

Free for 3 shows. No card needed.

Hosts & guests

No transcript yet

This episode has not been transcribed. Request it and it moves to the front of the queue.

Concerns over MDH spices, SC on VVPATs, and AstraZeneca's admission

3 Things

0:00
15:41

More episodes

More from 3 Things

View all episodes →